BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25152416)

  • 1. Production of monoclonal antibodies for breast cancer by HB8696 hybridoma cells using novel perfusion system.
    Kamthan S; Gomes J; Roychoudhury PK
    Enzyme Microb Technol; 2014 Oct; 64-65():44-51. PubMed ID: 25152416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silk screen based dual spin-filter module for perfusion culture of adherent and non-adherent mammalian cells.
    Kamthan S; Gomes J; Roychoudhury PK
    Biotechnol Lett; 2014 Aug; 36(8):1623-30. PubMed ID: 24737079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-up/step-down perfusion approach for increased mAb 520C9 production by a hybridoma cell line.
    Sen S; Roychoudhury PK
    Biotechnol Lett; 2013 Feb; 35(2):153-63. PubMed ID: 23086570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
    Chen Y
    Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
    Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
    Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of feeding rate on monoclonal antibody production in a modified perfusion-fed fermentor.
    Velez D; Reuveny S; Miller L; Macmillan JD
    J Immunol Methods; 1987 Sep; 102(2):275-8. PubMed ID: 3655377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
    Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
    Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybridoma stability.
    Castillo FJ; Mullen LJ; Grant BC; DeLeon J; Thrift JC; Chang LW; Irving JM; Burke DJ
    Dev Biol Stand; 1994; 83():55-64. PubMed ID: 7533731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
    Kundu PK; Prasad NS; Datta D
    Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic cell filter: a proven cell retention technology for perfusion of animal cell cultures.
    Shirgaonkar IZ; Lanthier S; Kamen A
    Biotechnol Adv; 2004 Jul; 22(6):433-44. PubMed ID: 15135491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated process for mammalian cell perfusion cultivation and product purification using a dynamic filter.
    Castilho LR; Anspach FB; Deckwer WD
    Biotechnol Prog; 2002; 18(4):776-81. PubMed ID: 12153312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of monoclonal antibody production after single and combination treatment of the hybridoma cells with all-trans retinoic acid and docosahexaenoic acid: An in vitro and in vivo study.
    Rokni M; Razavi AR; Shokri F; Ahmadi Kia K; Solaymani-Mohammadi F; Chahardoli R; Saboor-Yaraghi AA
    Int Immunopharmacol; 2018 Jun; 59():295-300. PubMed ID: 29677631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
    Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
    J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on monoclonal antibody production in murine hybridoma cell cultures of adenosine receptor antagonists and phosphodiesterase inhibitors.
    Kelso GF; Kazi SA; Harris SJ; Boysen RI; Chowdhury J; Hearn MTW
    Bioorg Med Chem Lett; 2016 Jan; 26(2):540-544. PubMed ID: 26646217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.